PCRX
Pacira BioSciences, Inc.
$23.15
-2.07%
2026-05-08
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.
Key Fundamentals
P/E Ratio
182.96
Forward P/E
6.60
EPS (TTM)
$0.13
ROE
0.7%
Revenue Growth (YoY)
5.0%
Profit Margin
0.7%
Debt/Equity
62.88
Price/Book
1.41
Beta
0.32
Market Cap
$935.9M
Avg Volume (10D)
735K
Recent Breakout Signals
No recent breakout signals detected for PCRX.
Recent Price Range (60 Days)
60D High
$27.13
60D Low
$20.62
Avg Volume
685K
Latest Close
$23.15
Get breakout alerts for PCRX
Sign up for Breakout Scanner to receive daily notifications when PCRX triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Pacira BioSciences, Inc. (PCRX) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PCRX daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PCRX operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry. Data is provided for informational purposes only and does not constitute financial advice.